MC4 receptor
Literature focuses on the centrally expressed MC4 receptor rather than peripheral melanocortin subtypes.
These are results measured on this lot. Full material specification is in Know your compound.
Melanocortin Peptide
A cyclic heptapeptide melanocortin agonist with MC4R-focused literature.
$22.50 per vial with BOGO
Research use only — not for human or veterinary use, diagnostic or therapeutic.
Know your compound
PT-141 (bremelanotide) is a cyclic heptapeptide derived from the Melanotan II scaffold. It is a metabolite-derived refinement of that molecule, developed toward activity at the MC4 receptor rather than the broad melanocortin activity of its parent.
That receptor shift is the whole reason the compound exists as a separate entity. MC4R is expressed centrally rather than in skin, and the published literature on this compound therefore concerns central nervous system pathways rather than the pigmentation endpoints associated with MC1R engagement.
Supplied as a lyophilized powder for laboratory research use only, with a lot-specific Certificate of Analysis. Nothing here describes an approved therapy or a use in humans.
Read left to right from the N-terminus. Mass spectrometry checks each lot against this sequence — that result is the “Identity” line on the certificate.
What the molecule is.
How we know the material matches the label.
What arrives, and how it is kept.
What the literature examines
Summaries of what published research has investigated. Preclinical unless stated otherwise — not claims about this product.
Literature focuses on the centrally expressed MC4 receptor rather than peripheral melanocortin subtypes.
Developed from the cyclic α-MSH scaffold, and the two are routinely compared in published melanocortin work.
Preclinical studies examine central nervous system signalling rather than dermatological endpoints.
Certificate of Analysis
Not a brand-wide spec sheet — a lot-specific certificate from an independent laboratory, published before the lot ships and searchable by lot number forever.
Independent U.S. laboratory
Certificate of Analysis · RFX-2606-062
| Test | Specification | Result |
|---|---|---|
| Purity (HPLC) | ≥ 99.0% | 99.4% |
| Identity (LC-MS) | Conforms | Conforms |
| Appearance | White powder | Conforms |
| Net content | Label claim | Conforms |
Questions
No. PT-141 is not an FDA-approved drug and is not approved for human or veterinary use. It is supplied exclusively as a research material for laboratory use, and it is not intended to diagnose, treat, cure, or prevent any disease.
Yes. Every lot is assayed by an independent U.S. laboratory for purity and identity, and the certificate for the lot you receive is published in our COA library — you can read it before you order.
Purity is quantified by reverse-phase HPLC against a reference standard, and identity is confirmed by mass spectrometry. Both results appear on the lot certificate.
Lyophilized material is typically stored cold and protected from light. Handling and storage are the responsibility of the receiving laboratory; refer to the lot documentation for specifics.
Every second vial is free, sitewide and automatically. Add two vials and you pay for one; add six and you pay for three. Compounds can be mixed, there is no code, and there is no limit.
Orders are processed promptly and shipped with tracking. Free US shipping applies over $100; Priority shipping is $8.95 otherwise.
The guarantee
Have any lot independently re-tested. If the results don't match the purity printed on its published certificate, we refund the order in full — no returns, no argument.
Same research area